The 2007 Clinical Trials Congress had one non-industry speaker: New York Yankees manager Joe Torre. He has survived both prostate cancer and working for George Steinbrenner. Torre basically lit up the room in Las Vegas, eliciting a mixture of questions about his decisions in bygone World Series and his ability…more...

Running ClinPage has forced us to learn a bit more about web-based reports. Scratch that. We are not sure we know anything. That may be a reach, as some readers regularly remind us. But we do love a web-based reporting tool described a few paragraphs down. Right off the bat,…more...

We’ve been reading Reinventing Patient Recruitment by Joan Bachenheimer and Bonnie Brescia. The subtitle: Revolutionary Ideas For Clinical Trial Success. This new reference work is suitable for site- and sponsor-side personnel who plan or work on patient recruitment. The authors are the founders of BBK Worldwide. ClinPage interviewed Bachenheimer a…more...

Techcrunch alerts us that Adobe is letting go of control of the PDF format, as this release shows. The recipient is the AIIM, the Enterprise Content Management Association. You’d think AIIM should be called the ECMA, but you’d be mistaken. As the release makes clear, there are at least half…more...

The numbers and details of the Pfizer job cuts were much as expected from news accounts last week. The company is firing another 7,800 people on top of the 2,200 job cuts already announced. The goal is to save an additional $2 billion, mostly by closing manufacturing sites. More than…more...

Pfizer is briefing Wall Street and the news media on big job cuts next week. Possible savings: an additional $800 million to $2 billion annually beyond the $4 billion in cuts announced already. The Wall Street Journal, among other news outlets, reports that an upcoming speech by Pfizer CEO Jeffrey…more...

In another post, we outlined the alarming tendency for the life sciences to shoulder a disproportionate share of the blame for what ails the U.S. medical landscape and economy. A maligned, demonized pharmaceutical industry is a prominent scape goat in Washington, as a new Congress is about to try to…more...

In the aftermath of 9/11, Newsweek did a cover story on the roots of Islamic hostility to the U.S. That story was titled “Why They Hate Us.” As 2007 begins, the same unsettling question can be asked of the life sciences. Why does the public hate pharma? There are no…more...

Here’s a summary of a forecast by the Gartner consultancy. The firm believes that more than $5 billion worth of IT outsourcing will shift away from the firms handling the business now. There is a mixture of amusing stuff and sobering stuff. Gartner thinks that the Windows operating system will…more...

A minor injury. You’re waiting in your local emergency room. At last, a physician approaches. Her secret weapon is … her brain? Years of rigorous, closely-supervised training? The latest diagnostic scanner? No. Google. Physicians frustrated by the lack of appropriately indexed and powerful reference works are turning to the world’s…more...